SOAT1 and breast cancer: This study demonstrated that miR‐449c‐5p inhibits breast cancer cell proliferation, migration and invasion by targeting ERBB2 via JAK/STAT, which means miR‐449c‐5p, is a potential biomarker for breast cancer and provides a novel insight for diagnosis.